1110 Stock Overview
Kingworld Medicines Group Limited, an investment holding company, distributes branded imported pharmaceutical and healthcare products.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Kingworld Medicines Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.51 |
| 52 Week High | HK$0.92 |
| 52 Week Low | HK$0.48 |
| Beta | 0.72 |
| 1 Month Change | -13.56% |
| 3 Month Change | -13.56% |
| 1 Year Change | -32.00% |
| 3 Year Change | -35.44% |
| 5 Year Change | -45.16% |
| Change since IPO | -75.12% |
Recent News & Updates
A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Mar 22
The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising
Nov 30Recent updates
A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Mar 22The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising
Nov 30Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement
Aug 17Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247
May 30The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing
May 11Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247
Apr 03Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture
Feb 07A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Oct 07Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business
Jul 05Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024
Apr 27We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)
Aug 17Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly
Apr 24Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)
Mar 29Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares
Mar 08Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?
Feb 15Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)
Jan 25
Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?
Dec 18We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt
Dec 05What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation
Nov 22Shareholder Returns
| 1110 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 2.0% | -0.5% | -2.8% |
| 1Y | -32.0% | -33.9% | -15.0% |
Return vs Industry: 1110 exceeded the Hong Kong Healthcare industry which returned -34.9% over the past year.
Return vs Market: 1110 underperformed the Hong Kong Market which returned -16.4% over the past year.
Price Volatility
| 1110 volatility | |
|---|---|
| 1110 Average Weekly Movement | 9.1% |
| Healthcare Industry Average Movement | 6.6% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 14.8% |
| 10% least volatile stocks in HK Market | 3.8% |
Stable Share Price: 1110's share price has been volatile over the past 3 months.
Volatility Over Time: 1110's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 1,002 | Li Sheng Zhao | www.kingworld.com.cn |
Kingworld Medicines Group Limited, an investment holding company, distributes branded imported pharmaceutical and healthcare products. The company also supplies pharmaceutical, healthcare, general foodstuffs, and medical products. It offers products for relieving cough, eliminating phlegm, soothing asthma, curing influenza, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, Kingworld Imada Red Flower Oil, Culturelle probiotics product series, Lifeline Care product serices, and Mentholatum product series brands.
Kingworld Medicines Group Limited Fundamentals Summary
| 1110 fundamental statistics | |
|---|---|
| Market cap | HK$317.48m |
| Earnings (TTM) | HK$41.22m |
| Revenue (TTM) | HK$1.17b |
7.7x
P/E Ratio0.3x
P/S RatioIs 1110 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1110 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.08b |
| Cost of Revenue | CN¥797.99m |
| Gross Profit | CN¥280.67m |
| Other Expenses | CN¥242.57m |
| Earnings | CN¥38.10m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.061 |
| Gross Margin | 26.02% |
| Net Profit Margin | 3.53% |
| Debt/Equity Ratio | 48.9% |
How did 1110 perform over the long term?
See historical performance and comparisonDividends
6.6%
Current Dividend Yield48%
Payout RatioDoes 1110 pay a reliable dividends?
See 1110 dividend history and benchmarks| Kingworld Medicines Group dividend dates | |
|---|---|
| Ex Dividend Date | Jun 03 2024 |
| Dividend Pay Date | Jun 28 2024 |
| Days until Ex dividend | 46 days |
| Days until Dividend pay date | 71 days |
Does 1110 pay a reliable dividends?
See 1110 dividend history and benchmarks